Viking Therapeutics (VKTX) Misses Q3 EPS by 1c

Viking Therapeutics (NASDAQ: VKTX) reported Q3 EPS of ($0.23), $0.01 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Nike names former Pfizer CFO David Denton as new finance chief
• SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters